These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10376976)

  • 1. Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid.
    Hussey HJ; Tisdale MJ
    Br J Cancer; 1999 Jun; 80(8):1231-5. PubMed ID: 10376976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a cancer cachectic factor on protein synthesis/degradation in murine C2C12 myoblasts: modulation by eicosapentaenoic acid.
    Smith HJ; Lorite MJ; Tisdale MJ
    Cancer Res; 1999 Nov; 59(21):5507-13. PubMed ID: 10554027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia.
    Bhogal AS; Lorite ML; Tisdale MJ
    Anticancer Res; 2006; 26(6B):4149-54. PubMed ID: 17201126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF).
    Lorite MJ; Smith HJ; Arnold JA; Morris A; Thompson MG; Tisdale MJ
    Br J Cancer; 2001 Jul; 85(2):297-302. PubMed ID: 11461093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia.
    Russell ST; Tisdale MJ
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):409-14. PubMed ID: 15899583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of cancer cachexia.
    Tisdale MJ
    J Support Oncol; 2003; 1(3):159-68. PubMed ID: 15334872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.
    Beck SA; Smith KL; Tisdale MJ
    Cancer Res; 1991 Nov; 51(22):6089-93. PubMed ID: 1657378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
    Smith HJ; Mukerji P; Tisdale MJ
    Cancer Res; 2005 Jan; 65(1):277-83. PubMed ID: 15665304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
    Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes.
    Mirza KA; Luo M; Pereira S; Voss A; Das T; Tisdale MJ
    In Vitro Cell Dev Biol Anim; 2016 Sep; 52(8):838-45. PubMed ID: 27194344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss.
    Cabal-Manzano R; Bhargava P; Torres-Duarte A; Marshall J; Bhargava P; Wainer IW
    Br J Cancer; 2001 Jun; 84(12):1599-601. PubMed ID: 11401311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
    Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
    Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
    Whitehouse AS; Tisdale MJ
    Biochem Biophys Res Commun; 2001 Jul; 285(3):598-602. PubMed ID: 11453634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of a tumor lipid-mobilizing factor by eicosapentaenoic acid.
    Price SA; Tisdale MJ
    Cancer Res; 1998 Nov; 58(21):4827-31. PubMed ID: 9809986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate.
    Smith HJ; Wyke SM; Tisdale MJ
    Cancer Res; 2004 Dec; 64(23):8731-5. PubMed ID: 15574784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by a cachectic-factor in murine myotubes and inhibition by eicosapentaenoic acid.
    Smith HJ; Tisdale MJ
    Apoptosis; 2003 Mar; 8(2):161-9. PubMed ID: 12766476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-host interactions.
    Tisdale MJ
    J Cell Biochem; 2004 Nov; 93(5):871-7. PubMed ID: 15449322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a human homologue to the murine proteolysis-inducing factor?
    Wieland BM; Stewart GD; Skipworth RJ; Sangster K; Fearon KC; Ross JA; Reiman TJ; Easaw J; Mourtzakis M; Kumar V; Pak BJ; Calder K; Filippatos G; Kremastinos DT; Palcic M; Baracos VE
    Clin Cancer Res; 2007 Sep; 13(17):4984-92. PubMed ID: 17785548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of muscle protein degradation induced by a cancer cachectic factor.
    Lorite MJ; Thompson MG; Drake JL; Carling G; Tisdale MJ
    Br J Cancer; 1998 Oct; 78(7):850-6. PubMed ID: 9764574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.